Geoff Meacham
Stock Analyst at Citi
(4.84)
# 412
Out of 4,651 analysts
1208
Total ratings
60.5%
Success rate
15.6%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $70 | $63.83 | +9.67% | 73 | Aug 14, 2026 | |
| VOR Vor Biopharma | Maintained: Buy | $50 | $23.03 | +117.11% | 3 | Aug 13, 2026 | |
| ABOS Acumen Pharmaceuticals | Maintained: Buy | $4 | $2.67 | +49.81% | 11 | Aug 13, 2026 | |
| APGE Apogee Therapeutics | Maintained: Hold | $135 | $134.55 | +0.33% | 17 | Aug 13, 2026 | |
| MANE Veradermics | Maintained: Buy | $160 | $112.71 | +41.96% | 9 | Aug 13, 2026 | |
| AMGN Amgen | Maintained: Hold | $345 → $405 | $415.21 | -2.46% | 45 | Aug 10, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $58 → $60 | $52.52 | +14.24% | 6 | Aug 7, 2026 | |
| PTGX Protagonist Therapeutics | Maintained: Buy | $130 → $175 | $155.10 | +12.83% | 12 | Aug 6, 2026 | |
| RPRX Royalty Pharma | Maintained: Buy | $66 → $70 | $58.60 | +19.45% | 27 | Aug 6, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $120 → $135 | $117.39 | +15.00% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $26.79 | - | 75 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $125 | $93.09 | +34.28% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $165 | $138.36 | +19.25% | 81 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $26 | $21.63 | +20.20% | 20 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 → $215 | $209.83 | +2.46% | 73 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $700 → $740 | $803.48 | -7.90% | 60 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $41 → $60 | $63.32 | -5.24% | 61 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $100 | $76.75 | +30.29% | 18 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $230 → $260 | $249.46 | +4.23% | 66 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $32.34 | +70.07% | 3 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,500 → $1,600 | $1,180.16 | +35.57% | 99 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $125 | $135.84 | -7.98% | 64 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $585 | $505.75 | +15.67% | 66 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $8.05 | -13.04% | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 | $71.70 | +4.60% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $26.98 | +103.85% | 4 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 | $260.35 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.60 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $67.34 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $1.58 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $53.55 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $3.55 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $9 | $13.95 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $25.64 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $58.07 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.7961 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $25.29 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $49.52 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.92 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $9.24 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $16.12 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $74.44 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $79.86 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $29.48 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $4.73 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $499.73 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $2.82 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $74.13 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $1.09 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $44 | $1.19 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $17.19 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.26 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $20 | $18.38 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $10.77 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49 → $75 | $8.86 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $1.15 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $32.19 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $3.47 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $9.74 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $31.04 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.175 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $15.15 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $62.14 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €77.81 | €136.30 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $0.1542 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $120.16 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $13 | $4.31 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $14.02 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $1.96 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $103 → $110 | $152.72 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.36 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $43.02 | $9.02 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $228.65 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $25.12 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $13.16 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $33.56 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.90 | n/a | 1 | Sep 17, 2012 |
Bristol-Myers Squibb Company
Aug 14, 2026
Maintained: Hold
Price Target: $70
Current: $63.83
Upside: +9.67%
Vor Biopharma
Aug 13, 2026
Maintained: Buy
Price Target: $50
Current: $23.03
Upside: +117.11%
Acumen Pharmaceuticals
Aug 13, 2026
Maintained: Buy
Price Target: $4
Current: $2.67
Upside: +49.81%
Apogee Therapeutics
Aug 13, 2026
Maintained: Hold
Price Target: $135
Current: $134.55
Upside: +0.33%
Veradermics
Aug 13, 2026
Maintained: Buy
Price Target: $160
Current: $112.71
Upside: +41.96%
Amgen
Aug 10, 2026
Maintained: Hold
Price Target: $345 → $405
Current: $415.21
Upside: -2.46%
Scholar Rock Holding
Aug 7, 2026
Maintained: Buy
Price Target: $58 → $60
Current: $52.52
Upside: +14.24%
Protagonist Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $130 → $175
Current: $155.10
Upside: +12.83%
Royalty Pharma
Aug 6, 2026
Maintained: Buy
Price Target: $66 → $70
Current: $58.60
Upside: +19.45%
Kymera Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $120 → $135
Current: $117.39
Upside: +15.00%
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $26.79
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: $130 → $125
Current: $93.09
Upside: +34.28%
Aug 4, 2026
Reiterated: Buy
Price Target: $165
Current: $138.36
Upside: +19.25%
Aug 4, 2026
Maintained: Buy
Price Target: $20 → $26
Current: $21.63
Upside: +20.20%
Aug 3, 2026
Maintained: Hold
Price Target: $200 → $215
Current: $209.83
Upside: +2.46%
Aug 3, 2026
Maintained: Hold
Price Target: $700 → $740
Current: $803.48
Upside: -7.90%
Aug 3, 2026
Maintained: Hold
Price Target: $41 → $60
Current: $63.32
Upside: -5.24%
Jul 29, 2026
Maintained: Buy
Price Target: $60 → $100
Current: $76.75
Upside: +30.29%
Jul 16, 2026
Maintained: Hold
Price Target: $230 → $260
Current: $249.46
Upside: +4.23%
Jul 16, 2026
Maintained: Buy
Price Target: $55
Current: $32.34
Upside: +70.07%
Jul 15, 2026
Maintained: Buy
Price Target: $1,500 → $1,600
Current: $1,180.16
Upside: +35.57%
Jul 15, 2026
Maintained: Hold
Price Target: $125
Current: $135.84
Upside: -7.98%
Jul 15, 2026
Maintained: Buy
Price Target: $585
Current: $505.75
Upside: +15.67%
May 7, 2026
Maintained: Sell
Price Target: $7
Current: $8.05
Upside: -13.04%
May 7, 2026
Maintained: Hold
Price Target: $75
Current: $71.70
Upside: +4.60%
Jan 30, 2026
Maintained: Buy
Price Target: $55
Current: $26.98
Upside: +103.85%
Jun 10, 2024
Maintained: Hold
Price Target: $170
Current: $260.35
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $22
Current: $1.60
Upside: n/a
Jun 4, 2024
Maintained: Buy
Price Target: $130
Current: $67.34
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $1.58
Upside: n/a
May 23, 2024
Maintained: Buy
Price Target: $100
Current: $53.55
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $3.55
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $14 → $9
Current: $13.95
Upside: n/a
May 13, 2024
Maintained: Buy
Price Target: $36
Current: $25.64
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $101
Current: $58.07
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.7961
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $25.29
Upside: n/a
Oct 11, 2023
Maintained: Sell
Price Target: n/a
Current: $49.52
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $1.92
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $9.24
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $16.12
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $74.44
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $79.86
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $29.48
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $4.73
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $499.73
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $2.82
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $74.13
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $1.09
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $83 → $44
Current: $1.19
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $17.19
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.26
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $28 → $20
Current: $18.38
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $10.77
Upside: n/a
Oct 8, 2021
Maintained: Hold
Price Target: $49 → $75
Current: $8.86
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Mar 19, 2021
Maintained: Buy
Price Target: $35
Current: $32.19
Upside: n/a
Jan 5, 2021
Maintained: Buy
Price Target: $70
Current: $3.47
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $9.74
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $31.04
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.175
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $15.15
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $62.14
Upside: n/a
Feb 20, 2020
Maintained: Hold
Price Target: €77.81
Current: €136.30
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $0.1542
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $120.16
Upside: n/a
May 2, 2019
Maintained: Hold
Price Target: $13 → $13
Current: $4.31
Upside: n/a
Mar 29, 2019
Maintained: Hold
Price Target: $8
Current: $14.02
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $27
Current: $1.96
Upside: n/a
Mar 28, 2019
Maintained: Buy
Price Target: $103 → $110
Current: $152.72
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $3.36
Upside: n/a
Feb 20, 2019
Rated: Buy
Price Target: $43.02
Current: $9.02
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $228.65
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $25.12
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $13.16
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $33.56
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $11.90
Upside: n/a